Search

Your search keyword '"Kaplan GB"' showing total 71 results

Search Constraints

Start Over You searched for: Author "Kaplan GB" Remove constraint Author: "Kaplan GB"
71 results on '"Kaplan GB"'

Search Results

2. Pharmacological Management of Sleep-Wake Disturbances in Delirium.

3. Neuroplasticity of the extended amygdala in opioid withdrawal and prolonged opioid abstinence.

4. Estrous cycle dependent expression of oxycodone conditioned reward in rats.

5. Disturbances in fear extinction learning after mild traumatic brain injury in mice are accompanied by alterations in dendritic plasticity in the medial prefrontal cortex and basolateral nucleus of the amygdala.

6. Mitochondrial dysfunction in animal models of PTSD: Relationships between behavioral models, neural regions, and cellular maladaptation.

8. Sleep-wake and arousal dysfunctions in post-traumatic stress disorder: Role of orexin systems.

9. Translational approaches to influence sleep and arousal.

10. Suppression and acceptance in unipolar depression: Short-term and long-term effects on emotional responding.

11. Opioid-induced structural and functional plasticity of medium-spiny neurons in the nucleus accumbens.

12. Pathophysiological Bases of Comorbidity: Traumatic Brain Injury and Post-Traumatic Stress Disorder.

13. Dopamine D1 receptor agonist treatment attenuates extinction of morphine conditioned place preference while increasing dendritic complexity in the nucleus accumbens core.

14. Acquisition of morphine conditioned place preference increases the dendritic complexity of nucleus accumbens core neurons.

15. Associations among smoking, anhedonia, and reward learning in depression.

16. Extinction of opiate reward reduces dendritic arborization and c-Fos expression in the nucleus accumbens core.

17. Repeated valproate treatment facilitates fear extinction under specific stimulus conditions.

18. Association between smoking and heart rate variability among individuals with depression.

19. Dendritic structural plasticity in the basolateral amygdala after fear conditioning and its extinction in mice.

20. Alterations in expression and phosphorylation of GluA1 receptors following cocaine-cue extinction learning.

21. Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls.

22. Changes in expression of c-Fos protein following cocaine-cue extinction learning.

23. The relationship between reward-based learning and nicotine dependence in smokers with schizophrenia.

24. Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia.

25. The use of cognitive enhancers in animal models of fear extinction.

26. Treatment of addiction and anxiety using extinction approaches: neural mechanisms and their treatment implications.

27. Opiate sensitization induces FosB/ΔFosB expression in prefrontal cortical, striatal and amygdala brain regions.

28. Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: role in pathogenesis and treatment.

29. Intolerance for Smoking Abstinence Questionnaire: psychometric properties and relationship to tobacco dependence and abstinence.

30. Baclofen enhances extinction of opiate conditioned place preference.

31. Intra-VTA adenosine A1 receptor activation blocks morphine stimulation of motor behavior and cortical and limbic Fos immunoreactivity.

32. Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls.

33. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.

34. A composite neural network model for perseveration and distractibility in the Wisconsin card sorting test.

35. Assessment of insight into delusional beliefs in schizophrenia using the Brown Assessment of Beliefs Scale.

36. Speech production in schizophrenia: preliminary data regarding voice onset time.

37. Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls.

38. Subjective and physiological responses to smoking cues in smokers with schizophrenia.

39. PROSSA challenge.

40. Baclofen as adjunctive treatment for a patient with cocaine dependence and schizoaffective disorder.

41. Antipsychotics regulate cyclic AMP-dependent protein kinase and phosphorylated cyclic AMP response element-binding protein in striatal and cortical brain regions in mice.

42. GABA(B) receptor activation in the ventral tegmental area inhibits the acquisition and expression of opiate-induced motor sensitization.

43. Baclofen inhibits opiate-induced conditioned place preference and associated induction of Fos in cortical and limbic regions.

44. Opiate-induced motor stimulation is regulated by gamma-aminobutyric acid type B receptors found in the ventral tegmental area in mice.

45. Naltrexone's effects on reactivity to alcohol cues among alcoholic men.

46. Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam.

47. Differential effects of treatment with typical and atypical antipsychotic drugs on adenylyl cyclase and G proteins.

48. Role of adenosine A1 and A2A receptors in the alcohol withdrawal syndrome.

49. Adenosine receptor antagonists inhibit the development of morphine sensitization in the C57BL/6 mouse.

50. Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation.

Catalog

Books, media, physical & digital resources